LBCA Releases New PSA on the Importance of Clinical Trial Participation

In this video, LBCA Executive Director, Laurie Hutcheson discusses the importance of participating in clinical trials to help in the discoveries of new treatments for breast cancer, along with Dr. Jason Mouabbi, Chair of the LBCA Scientific Advisory Board, breast cancer patients and patient advocates. Also discussed is the importance for individuals with all breast cancer types to be in clinical trials to ensure diversity.

Share this article:
Scroll to Top

Join Us

Subscribe for the Latest News & Updates​

  • This field is for validation purposes and should be left unchanged.